Related Experiment Video
Updated: May 5, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha
Anne Keriel1, Anne Stary, Alain Sarasin
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, BP 163, 67404 Illkirch Cedex, C. U., Strasbourg, France.
Abstract:
Inherited mutations in the XPD subunit of the general transcription/repair factor TFIIH yield the rare genetic disorder Xeroderma pigmentosum (XP), the phenotypes of which cannot be explained solely on the basis of a DNA repair defect. In cells derived from XP-D patients, we observed a reduction of the ligand-dependent transactivation mediated by several nuclear receptors (RARalpha, ERalpha, and AR). We demonstrate that the XPD mutation alters cdk7 function in RARalpha phosphorylation. Transactivation is restored upon overexpression of either the wild-type XPD or the RARalphaS77E (a mutation which mimics phosphorylated RARalpha). Thus, we demonstrate that the cdk7 kinase of TFIIH phosphorylates the nuclear receptor, then allowing ligand-dependent control of the activation of the hormone-responsive genes.
Insights
Mutations in the XPD gene, linked to Xeroderma pigmentosum (XP), impair nuclear receptor function beyond DNA repair. This study reveals XPD
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Xeroderma pigmentosum (XP) is a rare genetic disorder caused by mutations in the XPD gene, a component of the transcription/repair factor TFIIH.
- XP phenotypes suggest roles for XPD beyond DNA repair, but these are not fully understood.
Purpose of the Study:
- To investigate the non-DNA repair functions of the XPD gene.
- To explore the impact of XPD mutations on nuclear receptor-mediated transactivation.
Main Methods:
- Analysis of nuclear receptor transactivation in cells from XP-D patients.
- Investigating the role of XPD in the phosphorylation of the RARalpha nuclear receptor.
- Utilizing overexpression of wild-type XPD and a mutated RARalpha (RARalphaS77E) to assess functional restoration.
Main Results:
- XPD mutations reduce ligand-dependent transactivation of nuclear receptors like RARalpha, ERalpha, and AR.
- The XPD mutation impairs the cdk7 kinase activity within TFIIH, affecting RARalpha phosphorylation.
- Restoration of transactivation was observed with wild-type XPD or RARalphaS77E, indicating the importance of proper RARalpha phosphorylation.
Conclusions:
- The XPD subunit of TFIIH plays a crucial role in regulating nuclear receptor activity through phosphorylation.
- This phosphorylation, mediated by the cdk7 kinase, is essential for ligand-dependent gene activation.
- XPD's function extends beyond DNA repair, impacting hormonal gene regulation and potentially contributing to XP phenotypes.
Related Concept Videos
Abnormal Proliferation
Regulation of the Unfolded Protein Response
Receptor Tyrosine Kinases
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway

